Contact

PE Conjugated Human Her2 Protein (C-His)

Cat # Size Price Quantity
80440125 ug$245
804402100 ug$595

  Bulk/Custom

Product Details

ApplicationFC
FormatLiquid, PE
Expression HostCHO
Target NameHER2, HER-2, ERBB2, CD340, neu, MLN19, NEU, NGL, TKR1
SpeciesHuman
SourcesRecombinant Human Her2 protein (Thr23-Thr652) with C-terminus His tag is expressed in CHO cells and conjugated to PE.
Accession NumberP04626
Molecular WeightThe protein has a predicted molecular weight of 71 kDa. Under DTT-reducing conditions, it migrates at approximately 85 kDa on SDS-PAGE prior to conjugation.
Affinity TagC-His
Regulatory StatusRUO
Formulation1xPBS buffer, pH7.4, 0.09% NaN3 with a carrier protein
Endotoxin levelNot tested
Protein Concentration25µg size is bottled at 0.1mg/mL concentration. 100 µg size is bottled at lot specific concentration.
Storage and HandlingBriefly centrifuge the vial upon receipt. An unopened vial may be stored at 2–8°C for up to six months.

Background Information

ErbB2, also known as HER2, is a receptor tyrosine kinase that belongs to the ErbB family, which includes EGFR, ErbB2, ErbB3, and ErbB4. It plays a critical role in regulating cell growth, differentiation, and survival. Unlike other members of the ErbB family, ErbB2 does not have a ligand-binding domain. However, it can form homodimers or heterodimers with other ErbB receptors after they bind their respective ligands, leading to activation of downstream signaling pathways. ErbB2 gene amplification and protein overexpression are observed in approximately 20% of invasive breast cancers, contributing to increased aggressiveness and poor prognosis. ErbB2 is also overexpressed in other cancers, including gastric, salivary, and colorectal cancers. Trastuzumab (Herceptin), a humanized monoclonal antibody targeting ErbB2, is used in the treatment of HER2-positive breast and gastric cancers.

Data Sheets

PE Conjugated Human Her2 Protein (C-His) TDS

Have a product or application question? Consult our FAQs or contact us.